NCT03039257View on ClinicalTrials.gov

Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

January 17, 2018

Study Completion Date

March 28, 2018

Conditions
Hematopoietic Stem Cell Transplant
Interventions
DIETARY_SUPPLEMENT

Vitamin A

Dose administration will start with 2500 IU/kg with maximum dose of 250,000 IU orally.

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT03039257 - Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates | Biotech Hunter | Biotech Hunter